Next Article in Journal / Special Issue
Immunotherapeutic Applications of NK Cells
Previous Article in Journal
Design and Synthesis of Novel N-Arylsulfonyl-3-(2-yl-ethanone)-6-methylindole Derivatives as Inhibitors of HIV-1 Replication
Previous Article in Special Issue
Wharton’s Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2015, 8(2), 230-249; doi:10.3390/ph8020230

Seatbelts in CAR therapy: How Safe Are CARS?

1
Bone Marrow Transplantation and Cellular Therapy, University of Alabama at Birmingham, Birmingham, AL 35294-3300, USA
2
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030-2399, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Mark Murphy
Received: 9 December 2014 / Revised: 29 April 2015 / Accepted: 4 May 2015 / Published: 8 May 2015
(This article belongs to the Special Issue Cell Therapy)
View Full-Text   |   Download PDF [977 KB, uploaded 11 May 2015]   |  

Abstract

T-cells genetically redirected with a chimeric antigen receptor (CAR) to recognize tumor antigens and kill tumor cells have been infused in several phase 1 clinical trials with success. Due to safety concerns related to on-target/off-tumor effects or cytokine release syndrome, however, strategies to prevent or abate serious adverse events are required. Pharmacologic therapies; suicide genes; or novel strategies to limit the cytotoxic effect only to malignant cells are under active investigations. In this review, we summarize results and toxicities of investigations employing CAR redirected T-cells, with a focus on published strategies to grant safety of this promising cellular application. View Full-Text
Keywords: chimeric antigen receptor; suicide gene; safety switch; adoptive immunotherapy; cell therapy chimeric antigen receptor; suicide gene; safety switch; adoptive immunotherapy; cell therapy
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Minagawa, K.; Zhou, X.; Mineishi, S.; Di Stasi, A. Seatbelts in CAR therapy: How Safe Are CARS? Pharmaceuticals 2015, 8, 230-249.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top